PROCTER & GAMBLE HEALTH L - stock earnings
PGHL.NS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 720.7 million INR | 3.1 billion INR |
| 2023Q3 | 655.7 million INR | 3.0 billion INR |
| 2023Q2 | 298.2 million INR | 3.0 billion INR |
| 2023Q1 | 591.9 million INR | 3.2 billion INR |
| 2022Q4 | 768.0 million INR | 3.1 billion INR |
| 2022Q3 | 636.6 million INR | 3.0 billion INR |
| 2022Q2 | 411.5 million INR | 2.7 billion INR |
| 2022Q1 | 511.6 million INR | 2.7 billion INR |
| 2021Q4 | 448.4 million INR | 2.8 billion INR |
| 2021Q3 | 553.7 million INR | 2.7 billion INR |
| 2021Q2 | 338.9 million INR | 2.7 billion INR |
| 2021Q1 | 157.7 million INR | 2.2 billion INR |
| 2020Q4 | 678.8 million INR | 2.4 billion INR |
| 2020Q3 | 592.6 million INR | 2.6 billion INR |
| 2020Q2 | 488.6 million INR | 2.0 billion INR |
| 2020Q1 | 464.6 million INR | 2.3 billion INR |
| 2019Q4 | 382.1 million INR | 2.4 billion INR |
| 2019Q3 | 357.6 million INR | 2.3 billion INR |
| 2019Q2 | 440.8 million INR | 2.3 billion INR |
| 2019Q1 | 407.1 million INR | 2.3 billion INR |
| 2018Q4 | 7.2 billion INR | 2.0 billion INR |
| 2018Q3 | 523.3 million INR | 2.3 billion INR |
| 2018Q2 | 483.1 million INR | 2.2 billion INR |
| 2018Q1 | 227.1 million INR | 3.0 billion INR |
| 2017Q4 | 272.6 million INR | 3.0 billion INR |
| 2017Q3 | 316.9 million INR | 3.1 billion INR |
| 2017Q2 | 201.3 million INR | 2.6 billion INR |
| 2017Q1 | 148.3 million INR | 2.4 billion INR |
| 2016Q4 | 182.0 million INR | 2.5 billion INR |
| 2016Q3 | 275.4 million INR | 2.7 billion INR |
| 2016Q2 | 179.0 million INR | 2.6 billion INR |
| 2016Q1 | 122.5 million INR | 2.2 billion INR |
| 2015Q4 | 145.7 million INR | 2.4 billion INR |
| 2015Q3 | 125.2 million INR | 2.6 billion INR |
| 2015Q2 | 168.6 million INR | 2.5 billion INR |
| 2015Q1 | 96.2 million INR | 2.0 billion INR |
| 2014Q4 | 10.8 million INR | 2.1 billion INR |
| 2014Q3 | 175.8 million INR | 2.2 billion INR |
| 2014Q2 | 210.0 million INR | 2.3 billion INR |
| 2014Q1 | 35.6 million INR | 1.9 billion INR |
| 2013Q4 | 94.5 million INR | 2.2 billion INR |
| 2013Q3 | 157.7 million INR | 2.0 billion INR |
| 2013Q2 | 166.8 million INR | 2.0 billion INR |
| 2013Q1 | 139.8 million INR | 1.8 billion INR |
| 2012Q4 | 200.5 million INR | 1.9 billion INR |
| 2012Q3 | 258.0 million INR | 1.8 billion INR |
| 2012Q2 | 201.5 million INR | 1.8 billion INR |
| 2012Q1 | 123.9 million INR | 1.4 billion INR |
| 2011Q4 | 126.6 million INR | 1.3 billion INR |
| 2011Q3 | 199.9 million INR | 1.6 billion INR |
PGHL.NS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.3 billion INR | 12.4 billion INR |
| 2022 | 2.3 billion INR | 12.3 billion INR |
| 2021 | 1.9 billion INR | 10.9 billion INR |
| 2020 | 2.1 billion INR | 11.5 billion INR |
| 2019 | 2.5 billion INR | 13.6 billion INR |
| 2018 | 8.4 billion INR | 8.5 billion INR |
| 2017 | 939.1 million INR | 11.0 billion INR |
| 2016 | 758.9 million INR | 9.9 billion INR |
| 2015 | 535.6 million INR | 9.4 billion INR |
| 2014 | 432.2 million INR | 8.7 billion INR |
| 2013 | 558.8 million INR | 8.0 billion INR |
| 2012 | 784.0 million INR | 6.9 billion INR |
| 2011 | 636.8 million INR | 5.6 billion INR |
| 2010 | 631.8 million INR | 5.1 billion INR |
| 2009 | 654.8 million INR | 4.7 billion INR |
| 2008 | 630.1 million INR | 3.9 billion INR |
| 2007 | 688.2 million INR | 3.1 billion INR |
PGHL.NS
Price: ₹4,792.50
Dividend Yield: 0.02%
Forward Dividend Yield: 2.09%
Payout Ratio: 73.27%
Dividend Per Share: 100.00 INR
Earnings Per Share: 136.49 INR
P/E Ratio: 38.78
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 77.4 billion
Average Dividend Frequency: 1
Years Paying Dividends: 11
DGR3: 27.47%
DGR5: 30.00%